hrvatski glasnik intelektualnog vlasništva 05/2005 - Državni zavod ...
hrvatski glasnik intelektualnog vlasništva 05/2005 - Državni zavod ...
hrvatski glasnik intelektualnog vlasništva 05/2005 - Državni zavod ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
HR - Patenti. - Hrvatski <strong>glasnik</strong> <strong>intelektualnog</strong> vlasništva 12, 20<strong>05</strong>, 5, 1897 – 2089 1963<br />
predstavlja vodik, alkil, hidroksialkil, alkoksialkil, ili 0R'; B predstavlja<br />
vodik, alkil, hidroksialkil, alkoksialkil, ili 0R''; R' i R''su npr. nezavisno<br />
vodik, alkil, aralkil ili karbamoil.<br />
(51) Int.Cl. A 61 K 31/527 7 (10) HR P20<strong>05</strong>0223 A2<br />
C 07 D 239/80<br />
A 61 P 29/00<br />
(21) P20<strong>05</strong>0223A (22) 08. 03.20<strong>05</strong>.<br />
(43) 31. 10.20<strong>05</strong>.<br />
(86) PCT/IB03/003965; 08. 09.2003.<br />
(87) WO04/026818; 01. 04.2004.<br />
(31) 02292275.1 (32) 17. 09.2002. (33) EP<br />
(54) NOVI SPIROKONDENZIRANI KINAZOLINONI I NJIHOVA<br />
UPORABA KAO INHIBITORA FOSFODIESTERAZE<br />
NEW SPIROCONDENSED QUINAZOLINONES AND THEIR USE<br />
AS PHOSPHODIESTERASE INHIBITORS<br />
(71) Warner-Lambert Company LLC, 201 Tabor Road, Morris Plains, NJ<br />
07950, US<br />
(72) Patrick Bernardelli, UK Patent Department, Pfizer Limited,<br />
Ramsgate Road, Sandwich, Kent CT13 9NJ, GB<br />
Fabrice Vergne, UK Patent Department, Pfizer Limited, Ramsgate<br />
Road, Sandwich, Knet CT13 9NJ, GB<br />
Chrystelle Mendes, UK Patent Department, Pfizer Limited,<br />
Ramsgate Road, Sandwich, Knet CT13 9NJ, GB<br />
Pierre Gérard Ducrot, UK Patent Department, Pfizer Limited,<br />
Ramsgate Road, Sandwich, Knet CT13 9NJ, GB<br />
(74) Hraste & Partneri odvjetničko društvo, Zagreb, HR<br />
(57) Ovaj izum se odnosi na spojeve formule (I):<br />
gdje su R 1 , R 2 i m definirani u opisu, na njihovu uporabu kao lijeka, na<br />
farmaceutske pripravke koji ih sadrže i na procese njihove priprave. Ovi<br />
spojevi djeluju kao inhibitori fosfodiesteraze, a inhibiraju prije svega PDE-<br />
VII.<br />
(51) Int.Cl. A 61 K 31/54 7 (10) HR P20<strong>05</strong>0115 A2<br />
A 61 K 31/495<br />
A 61 K 31/535<br />
(21) P20<strong>05</strong>0115A (22) 03. 02.20<strong>05</strong>.<br />
(43) 31. 10.20<strong>05</strong>.<br />
(86) PCT/US03/021803; 11. 07.2003.<br />
(87) WO04/006842; 22. 01.2004.<br />
(31) 60/395,233 (32) 11. 07.2002. (33) US<br />
(54) KOMBINACIJA LIJEKOVA ZA TRETMAN NEOPLAZMI<br />
COMBINATIONS OF DRUGS FOR THE TREATMENT OF<br />
NEOPLASMS<br />
(71) CombinatoRx, Incorporated, 650 Albany Street, Boston, MA 02118,<br />
US<br />
(72) Alexis Borisy, 117 Gray Street, Arlington, MA 02476, US<br />
Curtis Keith, 42 Rutland Square, #2, Boston, MA 02118, US<br />
Michael A. Foley, 93 Wolcott Road, Chestnut Hill, MA 02467, US<br />
Brent R. Stockwell, 59 West Cedar Street, Apartment #4, Boston,<br />
MA 02114, US<br />
Debra, A. Gaw, 139 Oak Street, Reading, MA 01867, US<br />
James M. Nicholas, 8 Garrison Street, Apt. #409, Boston, MA<br />
02116, US<br />
Margaret, S. Lee, 20 Pleasant Street, Middleton, MA 01949, US<br />
(74) Dragomir Modrušan, ZAGREB, HR<br />
(57) Izum prikazuje metodu tretmana pacijenta koji ima karcinom ili<br />
drugu neoplazmu, a davanjem pacijentu istovremeno dva spoja ili u<br />
razmaku unutar 14 dana u količinama dovoljnim za tretman pacijenta.<br />
(51) Int.Cl. A 61 K 31/56 7 (10) HR P20<strong>05</strong>0355 A2<br />
(21) P20<strong>05</strong>0355A (22) 19. 04.20<strong>05</strong>.<br />
(43) 31. 10.20<strong>05</strong>.<br />
(86) PCT/US03/030156; 24. 09.2003.<br />
(87) WO04/030618; 15. 04.2004.<br />
(31) 60/413,040 (32) 24. 09.2002. (33) US<br />
60/417,261 09. 10.2002. US<br />
60/427,424 19. 11.2002. US<br />
60/427,526 19. 11.2002. US<br />
60/464,753 23. 04.2003. US<br />
(54) METODE I REAGENSI ZA TRETMAN BOLESTI I POREMEĆAJA<br />
POVEZANIH S POVEĆANIM RAZINAMA PROINFLAMATORNIH<br />
CITOKINA<br />
METHODS AND REAGENTS FOR THE TREATMENT OF<br />
DISEASES AND DISORDERS ASSOCIATED WITH INCREASED<br />
LEVELS OF PROINFLAMMATORY CYTOKINES<br />
(71) CombinatoRx, Incorporated, 650 Albany Street, Boston, MA 02118,<br />
US<br />
(72) Palaniyandi Manivasakam, 262 Vermont Street, West Roxbury, MA<br />
02132, US<br />
Brendan Smith, 1723 Washington Street #208, Boston, MA 02118,<br />
US<br />
Jason Fong, 3600 Chestnut Street Room 513, Philadelphia, PA<br />
19104, US<br />
Benjamin, A. Auspitz, 10 Chauncy Street, #33, Cambridge, MA<br />
02138, US<br />
James M. Nicholas, 8 Garrison Street, Apartment 409, Boston, MA<br />
02116, US<br />
Curtis Keith, 57 Warren Avenue, #1, Boston, MA 02116, US<br />
Grant, R. Zimmermann, 15 Chandler Street, Somerville, MA 02144,<br />
US<br />
Bradley, B. Brasher, 26 Fern Street, Natick, MA 01760, US<br />
Noah Sachs, 162 Dorchester Street, Boston, MA 02127, US<br />
Todd, W. Chappell, 39 Rutland Street, Apt. 1, Boston, MA 02118,<br />
US<br />
Grau Daniel, 34 Fairmont Avenue, Cambridge, MA 02139, US<br />
(74) Dragomir Modrušan, ZAGREB, HR<br />
(57) Izum prikazuje metodu tretmana pacijenta kojem je dijagnosticiran<br />
imunoupalni poremećaj ili je rizičan za njegov razvitak, a davanjem<br />
pacijentu SSRI ili njegovog analoga ili njegovog metabolita, te može i<br />
kortikosteroida ili drugog spoja. Izum također prikazuje farmaceutski<br />
pripravak koji sadrži SSRI ili njegov analoga ili metabolit i kortikosteroid ili<br />
drugi spoj za tretman ili prevenciju imunoupalnog poremećaja.<br />
(51) Int.Cl. A 61 K 31/56 7 (10) HR P20<strong>05</strong>0781 A2<br />
A 61 K 31/565<br />
A 61 K 31/568<br />
A 61 K 47/14<br />
(21) P20<strong>05</strong>0781A (22) 06. 09.20<strong>05</strong>.<br />
(43) 31. 10.20<strong>05</strong>.<br />
(86) PCT/IB04/000716; 15. 03.2004.<br />
(87) WO04/080383; 23. 09.2004.<br />
(31) PA200300399 (32) 14. 03.2003. (33) DK<br />
(54) METODE I FARMACEUTSKE MJEŠAVINE ZA POUZDANO<br />
POSTIZANJE PRIHVATLJIVIH RAZINA TESTOSTERONA U<br />
SERUMU<br />
METHODS AND PHARMACEUTICAL COMPOSITIONS FOR<br />
RELIABLE ACHIEVEMENT OF ACCEPTABLE SERUM<br />
TESTOSTERONE LEVELS<br />
(71) Schering Aktiengesellschaft, Muellerstr. 178, 13342 Berlin, DE<br />
(72) Doris Hübler, Ortsstrasse 12, 07407 Schmieden, DE<br />
Sabine Fricke, An der Riese 1b, 07749 Jena, DE<br />
Jan-Peter Ingwersen, Im Amseltal 10, 13465 Berlin, DE<br />
Wilhelm Kuhnz, Tegeler Weg 13, 13589 Berlin, DE<br />
(74) Dragutin Sikirić, Zagreb, HR<br />
ISSN 1331-2030